Fennec Pharmaceuticals (NASDAQ: FENC) reported Q1 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.81 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.